Cross-Linked Hyaluronate Gel Prefilled Syringe 30 MG/3ML

DEVICE2 trials

Sponsors

Andres Lopez Roldan, Vance Thompson Vision

Conditions

Chronic PeriodontitisDry Eye Disease (DED)Periodontal Bone Loss

Phase 4

Comparison of Clinical and Radiographic Parameters in the Application of Cross-linked Hyaluronic Acid 1.8% and Enamel Matrix Derivative in Periodontal Regeneration.

CompletedNCT04274244

Andres Lopez RoldanChronic Periodontitis, Periodontal Bone Loss

Start: 2020-03-01End: 2024-12-30Updated: 2026-08-03

Unknown Phase

Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery

RecruitingNCT07155057

Vance Thompson VisionDry Eye Disease (DED)

Start: 2025-09-03End: 2026-12-31Target: 60Updated: 2025-09-29

Related Papers

Comparision of crosslinked hyaluronic acid vs. enamel matrix derivative for periodontal regeneration: an 18-month follow-up randomized clinical trial

Clinical Oral Investigations2025-03-198 citations